Aurora kinase inhibitor CCT129202, Purity ≥98%

Synonym: CCT129202; 942947-93-5; CCT-129202; 2-(4-(6-Chloro-2-(4-(dimethylamino)phenyl)-1H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide; CHEMBL392525; 8N349V9Q27; 2-(4-(6-Chloro-2-(4-(dimethylamino)phenyl)-3H-imidazo[4,5-b]pyridin-7-yl)piperazin-1-yl)-N-(thiazol-2-yl)acetamide; Aurora kinase inhibitor

CAS Number: 942947-93-5
Compound CID: 16202152

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CCT129202, soluble in DMSO and insoluble in ethanol and water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A, Aurora B, and Aurora C.

Molecular Weight

497

Molecular Formula

C₂₃H₂₅ClN₈OS

Targets

Aurora A: 42 nM; Aurora B: 198 nM; Aurora C: 227 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 3 mg/mL (6.03 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

CCT129202 can be used in examining the inhibition of Aurora kinases and its effects on tumor cells.

Storage

Store at -20ºC.